Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy.
G A Amos BurkeAuke BeishuizenDeepa BhojwaniBirgit BurkhardtVéronique Minard-ColinRobin E NorrisEdita KabickovaF Guclu PinarliNurdan TacyildizAngela HowesJan de JongGrace LiuKerri NottageMariya SalmanXavier Woot de TrixheMitchell CairoPublished in: Leukemia (2020)